Strides Pharma Science informs about outcome of board meeting

24 Jan 2023 Evaluate

Strides Pharma Science has informed that it enclosed the Unaudited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter and nine months ended December 31, 2022, as approved by the Board of Directors of the Company at their meeting held today, along with a press release issued in this regard. The Board Meeting commenced at 12:45 hrs and concluded at 14:30 hrs.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

890.00 11.05 (1.26%)
07-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1507.00
Dr. Reddys Lab 6037.55
Cipla 1497.30
Zydus Lifesciences 1058.45
Lupin 1630.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.